 |
|
|||||
|
||||||
        |
||||||
|
|
 |
|||||
|
|
|
|
|||
|
|
|||||
| Momenta Pharmaceuticals
Announces Date of Earnings Release and Conference Call for Fourth Quarter
2005 Financial Results |
||||||
| CAMBRIDGE, MA — January 18,
2006 – Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology
company developing drugs based on its proprietary sugar sequencing technology,
will report its financial results for the fourth quarter ended December
31, 2005 before the U.S. financial markets open on Tuesday, February 14,
2006. Management will host a conference call on that date at 10:00 am EST to discuss these results and provide an update on the company. To access the call, please dial 866-700-7101 (domestic) or 617-213-8837 (international) prior to the scheduled conference call time and provide the access code 99544498. A replay of the call will be available approximately two hours after the call and will be accessible through March 14, 2006. To access the replay, please dial 888-286-8010 (domestic) or 617-801-6888 (international) and provide the access code 88978192. A live audio webcast of the call will be available on the “Investors” section of the Company’s website, www.momentapharma.com. Please go to the site at least 15 minutes prior to the call in order to register, download, and install any necessary software. An archived version of the webcast will be posted on the Momenta website approximately two hours after the call and will be available through March 14, 2006. About Momenta: To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release. Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners. Contact:
|
|
|||||
|
|
|
||||
|
|
|
|
|||
